Introduction
glycosylated protein of |260 kDa consisting of 2016 amino acid residues [7] . It is encoded by the SCN5A gene The voltage-gated cardiac sodium channel is responsible [8] , which is located on chromosome 3p21 [9] . At least 11 for the generation of the rapid upstroke of the myocardial other different genes that encode highly homologous action potential and thereby plays a central role in exsodium channel a-subunit isoforms expressed in the heart, citability of myocardial cells. In addition, since the action muscle and nervous system have been hitherto identified in potential upstroke velocity -in conjunction with the man (http: / / www.ncbi.nlm.nih.gov / entrez / query.fcgi?db extent of intercellular communication via gap junctions [1] 5Nucleotide). They display a modular architecture (Fig. -also determines impulse conduction velocity in cardiac 1), which consists of four internally homologous domains tissue, this channel also plays a vital role in impulse (DI-DIV) each made up of six transmembrane segments propagation. Mutations in the gene encoding this channel (S1-S6). The interdomain linkers and the N-and C-(SCN5A; Section 2.1) have been linked to three forms of terminal ends of the channel protein are all located primary electrical disease -the long QT syndrome cytoplasmically. (LQTS) [2] , the Brugada syndrome (BS) [3] and cardiac
Immunocytochemical experiments conducted in adult rat conduction defects [4] . The elucidation of the heart tissue revealed that in addition to the expected 1 1 pathophysiological mechanisms of these mutant Na chanlocalization of Na channels at the surface and t-tubular 1 nels would ultimately enable more specific pharmacomembranes, Na channels localize to terminal intercalated logical intervention in the management of these syndromes disks [10] , also the predominant sites of gap junctional and other related arrhythmias.
coupling. It has been proposed that this subcellular localization could play a role in anisotropic or saltatory conduction, or may act as a localized voltage-dependent current 2. Cardiac sodium channel amplifier [10] .
1
The cardiac Na channel (see Ref. [5] for review) is a 2.1.1. Permeation 1 member of the voltage-dependent family of Na channels The four domains of the channel fold around a central (see Ref.
[6] for review). These channels consist of ion-conducting pore [11] , which is lined by the S5-S6 heteromeric assemblies of an a-subunit, the pore-forming linker (referred to as the P-segment or P-loop) from each component, the function of which is modulated by associadomain [12] . This loop, which exhibits a high degree of tion with one or two ancillary b-subunits.
conservation among the various organ-specific isoforms across species, determines selectivity and conductance 2.1. a-Subunit properties of the channel [13] . Each of the four P-loop domains has a unique primary structure and a different 1 The human cardiac Na channel a-subunit is a heavily positioning relative to the permeation pathway [14] [15] [16] . Thus, the P-loop from each domain exerts a unique contribution towards the ion selectivity, ion and toxin binding properties and permeation characteristics of the 2.1.2. Gating 1 channel. In particular, the P-loops of domains III and IV Na channels transit among various conformational 1 play an important role in Na selectivity. A lysine residue states in the process of voltage-dependent gating. Depolarin the P-loop of DIII (K1418 in SCN5A), is critical for ization from the resting membrane potential triggers
discrimination for Na over Ca [13, 17] , and, in DIV, activation (opening) of the Na channels. If the depolarmutations of the tetrad WDGL (residues 1713-1716 in ization is maintained, the channels enter a non-conducting SCN5A) affect selectivity among monovalent cations [14] . inactivated state. Subsequent to repolarization, the chanIn line with the analogy of ion channels as enzymesnels return to a closed state capable of being activated once catalysing selective passage of ions across the cell memagain. It is becoming increasingly clear that these probrane [18] -it has been shown that P-loops are recesses are the result of complex allosteric interactions markably flexible structures [19, 20] and that this flexibility among many structural domains of the channel. could enhance selective ion translocation [19] .
The fourth transmembrane segment in each domain (S4,
The cardiac Na channel differs from the neuronal and Fig. 1 ) functions as a voltage sensor and is responsible for skeletal muscle isoforms in its sensitivity to block by activation gating [23] . It contains positively charged tetrodotoxin (TTX). Whereas brain and skeletal muscle residues at every third position (arginine or lysine), which isoforms are blocked at nanomolar concentrations of TTX, bring about motion of S4 segments in response to depolarthe heart isoform is blocked at micromolar concentrations.
ization [24] [25] [26] , leading to opening of the channel pore. Residues in the P-loop of DI are responsible for this All four S4 segments contribute to voltage-dependent 1 isoform-specific difference in toxin binding. A cysteine at activation of the Na channel; however, differentiation in position 373 within the heart isoform is responsible for the function between the four domains is also evidenced here. relative TTX resistance of this isoform, whereas the Positively charged residues at comparable positions within presence of aromatic residues (tyrosine or phenylalanine) the different S4 segments contribute unequally towards the at the corresponding position in the skeletal muscle and voltage-dependent properties of the channel [27] . The neuronal isoforms renders them TTX sensitive [21] . This structure(s) that forms the actual gates is yet unknown, but single amino acid difference is also responsible for the is expected to lie on the cytoplasmic side of the channel 21 susceptibility of the cardiac isoform to Cd block, [6] . compared to the insensitivity of the neuronal and skeletal Inactivation is characterized by at least two distinguishmuscle isoforms to block by this divalent cation [22] .
able kinetic components, an initial rapid component with a 1 fast recovery time constant (fast inactivation) and a slower muscle. The brain Na channel consists of the a-subunit, a component with a slower recovery time constant (slow non-covalently bound b1-subunit and a disulfide-linked 1 inactivation). Fast inactivation is mediated, at least in part, b2-subunit [56, 57] . The skeletal muscle Na channel by the DIII-DIV cytoplasmic linker (Fig. 1) [23, 28] . This consists of the a-subunit and a non-covalently linked linker can be visualized as a hinged lid, which docks b1-subunit [58, 59] . These b1-and b2-subunits are unreagainst receptor sites surrounding the inner vestibule of the lated proteins of 36 and 33 kDa, respectively, each pore, thereby occluding the pore. A critical component of consisting of a small C-terminal cytoplasmic domain, a DIII-DIV required for fast inactivation has been localized single transmembrane segment, and a large glycosylated to the highly conserved hydrophobic triad IFM (residues N-terminal extracellular domain [60] [61] [62] . 1485-1487 in the cardiac isoform) [29] . These residues are
The human b1-subunit is a 218-amino-acid protein [63] thought to interact with a receptor site that becomes encoded by the SCN1B gene located on chromosome 1 available in the activated Na channel [29, 30] . The S4-S5 19q13. 1 [64] . It is highly expressed in the heart, skeletal linkers in domains III and IV [31] [32] [33] [34] [35] and residues on the muscle and brain [62] . Co-expression of brain or skeletal 1 cytoplasmic end of S6 of DIV [36] could form part of this Na channel a-subunit isoforms with the b1-subunit in receptor site. It has also been proposed that rather than Xenopus oocytes have consistently demonstrated a larger being involved in direct interaction with the IFM motif peak I amplitude, acceleration of activation and inactivaNa itself, S6 could be critical for fast inactivation by stabiliztion, and a more negative voltage dependence of steadying the inactivation state through an indirect mechanism state inactivation than the a-subunit expressed alone [37] . [60, 62, 63, [65] [66] [67] [68] [69] [70] , demonstrating that co-expression with Structural determinants of slow inactivation are less the b1-subunit recapitulates the characteristics of the known but are most probably localized within P-loops. It channels observed in vivo by modulating their gating and has been demonstrated that slow inactivation can be increasing the efficiency of their expression. modulated by mutation of elements within the P-loops Contrary to the clear role of the b1-subunit in skeletal [38] [39] [40] [41] [42] , and that transposition of all four human heart muscle and the nervous system, the occurrence of such an isoform P-loops into the human skeletal muscle isoform interaction with the cardiac a-subunit isoform in vivo is (hSKM1) backbone conferred heart isoform-like slow not clear. Studies using subunit-specific antibodies have inactivation properties on the chimeric construct [43] . This identified the b1-subunit polypeptide in the heart [71] . suggests that slow inactivation in Na channels involves b1-subunit mRNA has also been detected by Northern blot conformational changes in the outer pore in a fashion analyses [60, 67, 68, 62] , in situ hybridization [72] as well as 1 analogous to C-type inactivation in K channels [44, 45] . RT-PCR on RNA from isolated ventricular myocytes [73] . Flexibility of the P-loops [19, 20] could affect this process However, immunoprecipitation experiments suggest that [46] . the cardiac a-subunit isoform is not associated with a Inactivation derives most of its voltage dependence from b-subunit [74] .
1 being coupled to activation [47] . This implies that the rate Moreover, co-expression studies of the cardiac Na of inactivation increases as a consequence of conformachannel a-subunit with the b1-subunit in Xenopus oocytes tional changes in the channel associated with activation.
have produced conflicting results. Some investigators The molecular details underlying the coupling of inactiva- [62, 68] reported no effect of the b1-subunit on the kinetics 1 tion to activation are starting to be unravelled. It appears of the cardiac Na channel a-subunit. Others [70, 72] have that the voltage sensing S4 segments, at least of DIV, play reported little or no effect on the kinetics or voltage 1 a crucial role in this process [48] [49] [50] [51] [52] [53] [54] 24, 35] . Movement of dependence of the Na current but showed a substantial 1 the voltage sensors in the activation pathway possibly increase in Na channel expression manifested as an brings about a reorganisation of the docking site for the increase in peak current amplitude. Another group [73] inactivation gate, thereby easing binding of the inactivation reported a 3-7 mV shift in the depolarizing direction in the gate. Another mechanism based on a physical interaction voltage dependence of inactivation upon co-expression of between regions on the S4-S5 linker of DIV and the the b1-subunit. Wei et al. [75] also reported a 10-mV shift DIII-DIV inactivation particle has also been proposed in the depolarizing direction upon co-expression with the [55] . It has been suggested that such an association could b1-subunit. A more recent study in human embryonic be sensitive to changes in the conformation of S4-S5 of kidney (HEK 293) cells has also shown a shift (11 mV) in DIV, which are brought about by movement of the voltage the depolarising direction upon co-expression of the a-and sensor in that domain during activation. This would result b1-subunits compared to expression of the a-subunit alone in a change in the position of the inactivation gate relative [76] . Suppression of b1 expression in mouse atrial tumor to its docking sites.
(AT-1) cells by antisense oligonucleotides resulted in a reduction in I amplitude, slower activation and inactivaNa 2.2. b1-Subunit tion, and a less negative voltage dependence of inactivation [77] , effects which are in accordance with those Auxiliary (b) subunits have been shown to be important observed for b1 on the brain and skeletal muscle a-1 modulators of Na channels from brain and skeletal subunits. This data, together with the fact that transcription of the b1-subunit increases dramatically postnatally [77] , dependence of steady-state inactivation and a reduction in suggest that the a-b1 interaction underlies the developcurrent amplitude [97] . mental change of I from the neonatal phenotype to the Na adult phenotype [77] which is characterized by much more 3. Long QT syndrome rapid activation and inactivation and a more negative mid-point for inactivation [78] . Development of a mature
The LQTS (Ref. [98] for review) is an inherited cardiac I is also promoted by an intracellular signalling event Na arrhythmia that may cause abrupt syncope, seizures and [78] [79] [80] . However, the mechanism explaining the relationsudden death from ventricular tachyarrhythmias, specificalship between intracellular signalling and a-b1 interaction ly torsades de pointes, and ventricular fibrillation. In still needs to be worked out. The developmental phenoaddition to the prolonged QT-interval, electrocardiographic typic change in I could underlie the increase in maxiNa abnormalities include T-wave abnormalities such as notmum upstroke velocity and conduction velocity observed ched or biphasic T waves, T-wave alternans, prominent U with development [81] .
waves and bradycardia. This syndrome arises from delayed 1 Expression studies on two naturally occurring Na repolarization of cardiomyocytes resulting from an imbalchannel mutants associated with LQTS type 3 (LQTS ) 3 ance in the inward and outward currents during the and the BS, respectively, have shown that their functional repolarization phase of the myocardial action potential. It defect was accentuated by co-expression of the b1-subunit has been estimated to affect 1 in 5000 individuals. (Sections 3.1 and 4.2; Tables 1 and 2 ), hinting at an LQTS is often transmitted in families as an autosomal interaction in vivo. On the other hand, mutations in SCN1B dominant trait and less often as an autosomal recessive have so far been linked only to febrile seizures and trait combined with congenital sensorineural deafness. In generalized epilepsy [82] .
some families a very low penetrance for the disorder has Structural correlates for the a-b1 interaction are been described [99] . thought to reside on the extracellular and intramembraOne subtype of this disorder -LQTS -is caused by caused by mutations in genes encoding subunits of redomain of the a-subunit could also play a role [76] . A role polarizing delayed rectifier potassium channels, namely 1 for the b1-subunit in Na channel localization has been KCNQ1, KCNH2, KCNE1, and KCNE2. An as yet proposed on the basis of the inferred immunoglobulin-like unidentified gene for this disorder has been mapped to structure of its large extracellular domain [87] . chromosome 4 [98] .
Second messenger regulation

SCN5A mutations in LQTS 3
Signalling pathways that may play a role in regulation of Mutations in SCN5A were linked to LQTS by a 3 1 cardiac Na channel function include those leading to positional candidate gene approach. Jiang et al. [100] activation of cAMP-dependent protein kinase (protein mapped the LQTS locus to 3p21-24. SCN5A was soon 3 kinase A, PKA) and protein kinase C (PKC). Modulation after mapped to chromosome 3p21 [9] , making it an by PKA occurs via phosphorylation at two serine residues excellent candidate gene for LQTS . In the same year, 3 (S525 and S528 in the human cardiac isoform) within the Wang et al. [2] reported an identical SCN5A mutation -DI-DII linker [88] . Phosphorylation by PKA at these sites deletion of residues K1505, P1506, Q1507 (DKPQ) -in 1 augments the Na current [88] [89] [90] . However, there have affected members of two families. [75, 105] ; T1304M, T1645M [106] ). The biophysical propspecies, at different stages of development and possibly erties of almost all LQTS -related mutant channels (all 3 also from different parts of the heart. except for T1304M and T1645M channels) have been Moreover, in addition to the indirect pathway mediated investigated by expression in Xenopus oocytes or mamby G-proteins acting through second messenger cascades, a malian cell lines (Table 1 ). All are associated with the 1 direct membrane-delimited G-protein regulatory pathway occurrence of Na channels with altered properties. involving direct interaction of the stimulatory G-protein Heterologous expression of DKPQ, N1325S and 1 a-subunit with the cardiac Na channel has also been put R1644H mutant channels [32, 107, 108] demonstrated that forward [91, 93, 94] .
these channels display macroscopic current decay rates Modulation by PKC occurs via phosphorylation at comparable to the wild-type channel, or may even have S1505 in the DIII-DIV inactivation gate [97] . Phosphorylfaster decay rates (Table 1 , DKPQ mutant), but exhibit ation at this site results in a negative shift in the voltagesmall persistent inward currents resulting from channel reopening during the late phase of a depolarizing stimulus. sion with the b1-subunit [75] . In tsA201 cells a faster The late-opening behaviour is more extensive in the case recovery from inactivation was also demonstrated [105] . of the DKPQ mutant. The DKPQ mutation is located in the The effect of this substitution is probably mediated through inactivation gate (DIII-DIV linker involved in fast inan allosteric mechanism, which disrupts critical conformaactivation) of the channel while the N1325S and R1644H tional changes involved in channel gating. mutations are located on the intracellular surface at sites The R1623Q mutation [41, 109] in the DIVS4 segment is that could constitute docking sites for the inactivation gate associated with a small persistent inward current, and a (Section 2.1.2). Hence, a possible molecular mechanism markedly slowed rate of macroscopic current decay caused for the anomalous behaviour of these channels is that these by a decreased rate of transition from the open state to the mutations compromise the ability of the inactivation gate inactivated state. The inactivation defect of this mutant to bind to its docking sites [32, 107] . The DII-DIII linker channel may be attributed to uncoupling of inactivation S941N mutation was described recently in a case of from activation as has been suggested for the analogous 1 sudden infant death syndrome associated with QT mutations in DIVS4 of the human skeletal muscle Na prolongation [101] . When expressed in oocytes [101] , this channel a-subunit, R1448H and R1448C [48, 110] . Such an 1 mutant Na channel also displayed an enhanced late effect is in line with the role of DIVS4 in inactivationcurrent. The mechanism whereby substitution within this activation coupling (Section 2.1.2). part of the channel protein leads to a persistent inward Pharmacological studies on lidocaine blockade of the current is yet unclear.
R1623Q channel by Kambouris et al. [111] have increased The E1784K substitution is located in the highly conour insight into the mechanisms of block of normal and the DKPQ channel is via the same mechanism. In the latter expression of D1790G mutant channels with the b1-channels, lidocaine drives these channels into the inactisubunit failed to produce such a shift. The mechanism by vated state, thereby attenuating their late reopenings and which this mutation prolongs repolarization is, however, bursts.
unclear. It has been suggested that the mutation prolongs The sustained inward current caused by the S941N, the action potential indirectly by alteration of the balance DKPQ, N1325S, R1644H, R1623Q and E1784K mutations of net plateau currents secondary to a reduction in inward 1 1 potentiates the small depolarizing Na current at the Na current during the action potential upstroke [113] . plateau phase of the cardiac action potential [112] . This
The slower upstroke and the less positive overshoot of the provides a direct explanation for the delayed ventricular action potential during the very early stages of ventricular 21 repolarization in LQTS patients harbouring these mutadepolarization could cause an increase of Ca entry via 21 21 tions. Moreover, the slower current decay of R1623Q L-type Ca channels. The alteration in Ca transient that channels (Table 1 ) may augment the effect of sustained follows could subsequently affect calcium-sensitive procurrent on action potential prolongation, and the faster cesses thereby resulting in net increase of inward plateau recovery from inactivation of DKPQ, R1644H, and current and corresponding increase in action potential E1784K channels (Table 1 ) may contribute to arduration [113] . rhythmogenesis.
SCN5A transcripts have recently been demonstrated in However, one of the LQTS mutations characterised to limbic circuitry of rat brain [114] . It may thus be specu-3 date, the D1790G mutation, is not associated with a lated that patients in whom prolonged QT interval presents persistent inward current [76] . This mutation appears to in conjunction with epileptic seizures [115] , may harbour alter a-b1 subunit interaction. Voltage-dependence of mutations in SCN5A. steady-state inactivation of monomeric D1790G channels was similar to that of monomeric wild-type channels. 3 However, whereas in the case of the wild-type channel intervention co-expression with the b1-subunit shifted the steady-state inactivation by 11 mV to more positive potentials, coWhereas functional studies on almost all SCN5A mu-tants associated with LQTS have been published (Section In a study on six LQTS patients, namely DKPQ and 3 3 3.1), there is a remarkable paucity of clinical data on R1644H carriers, Schwartz et al. [129] demonstrated that mutation carriers. Data from the LQTS registry group five had a significant shortening of QT-interval in response demonstrate the occurrence of a higher percentage of lethal to mexiletine. Rosero et al. [130] reported shortening of events in LQTS patients compared to LQTS and LQTS QT-interval in two DKPQ carriers by short-term intraven-
Clinical features of LQTS and pharmacological
patients [116] . Events in general occur at a relatively later ous lidocaine and long-term tocainide therapy. Also, the age in LQTS patients [116] . In contrast to LQTS and single patient with the R1623Q mutation responded 3 1 LQTS , QT-prolongation is equal in males and females favourably on lidocaine [41] . The specificity of lidocaine 2 and there is no age-difference [117] . Bradycardia could be block for LQTS , however, is doubted since QT interval 3 part of the clinical picture, at least for some mutant also shortens in response to lidocaine in LQTS patients 2 1 channels. Patients carrying the DKPQ mutation have [131] . The specificity of Na channel blockers for LQTS 3 significant resting bradycardia and maximum exercise rate has also been questioned by experimental studies showing is attenuated as well ( [118] , A. Moss, personal communithat mexiletine is also effective in suppressing torsades de cation). There is a trend towards lower heart rate in pointes in LQTS and LQTS models, due to an effect of 1 2 D1790G carriers and sinus arrest has been documented in the drug to reduce transmural dispersion of repolarization three carriers of this mutation [76, 119] . In the family and despite a relatively small effect of the drug to reduce described with the E1784K mutation, the proband's father, QT interval [127, 132] .
1 who also carried the mutation, had sinus bradycardia (32 However, Class IB Na channel blockade may not bpm) and occasional sinus pauses [75] . Decreased heart constitute a universal therapeutic approach to LQTS . As 3 rate and occurrence of patients with asystolic episodes are predicted on the basis of the absence of sustained inward 1 also the case in carriers of the 1795insD SCN5A mutation Na current in D1790G mutant channels [76] , lidocaine described in a kindred with a combined LQTS -BS did not correct QT-prolongation in the two D1790G 3 phenotype [120, 121] (see Section 4.2). In the latter pacarriers tested [119] . However, the Class IC agent tients, but also in DKPQ and D1790G carriers, prolonged flecainide induced significant shortening of repolarization conduction parameters at different cardiac levels are parameters among carriers of this mutation [119] . A reported [119] [120] [121] [122] [123] .
preliminary report suggested that this therapeutic effect LQTS mutations are associated with a gain-of-function could be due to sensitivity of mutant channels to flecainide 3 defect, and it is therefore immediately apparent that a use-dependent block and slower recovery from block gene-specific therapeutic approach targeted at blocking the [133] . Although there are also indications that flecainide 1 persistent inward Na current responsible for action could also be effective in DKPQ carriers (A. Moss, potential prolongation in this form of the disorder could personal communication), it is still unclear whether become feasible. Data from experimental models mimickflecainide can be used for all LQTS defects. Nevertheless, 3 ing LQTS as well as the very limited clinical data at this stage it appears that pharmacological intervention 3 1 available, suggest that Na channel blockers such as should be restricted to a research environment where lidocaine and its analogue mexiletine could constitute a correlation between type of mutation, electrophysiological specific therapy in patients with defects associated with characteristics of the mutated channel and outcome of 1 sustained inward Na current. In mammalian expression channel blockade is possible. systems, these Class IB agents are able to preferentially Theoretically pacemaker therapy is also likely to be very block the late-opening DKPQ [124, 125] , R1644H [125] effective in management of LQTS , because attenuation of 3 1 and N1325S [125] mutant Na channels at a low con-QT-interval prolongation is seen at faster rates both in 1 centration [125] without greatly modifying peak Na LQTS patients [129] and in experimental models mimick-3 current. This implies that pharmacological shortening of ing LQTS [126, 127] . Indeed, in the family with the 3 QT-interval in carriers of these mutations could be possible 1795insD mutation, long-term pacemaker therapy proved without compromising the spreading of excitation through very effective [121] . the heart.
The prolonged guinea pig ventricular myocyte action potential in an in vitro (anthopleurin A) model mimicking 4. Brugada syndrome LQTS was shortened by mexiletine [126] . In experiments 3 on the arterially perfused wedge [127] val, reduce transmural dispersion of repolarization and V3 (unrelated to ischemia, electrolyte abnormalities, or prevent torsades de pointes. This effect was secondary to a structural heart disease). The ECG pattern is dynamic and preferential effect of the drug to abbreviate the action varies presumably with varying risk of developing venpotential duration of the M cell and to suppress the tricular fibrillation [137] . Right bundle branch block, left development of early afterdepolarizations in these cells.
axis deviation and increased HV interval, indicative of conduction disturbances, are frequently present 'spike-and-dome' morphology caused by a pronounced [134, 135, 138, 139] . Right bundle branch block morphology transient outward (I ) current-mediated phase 1 [146, 147] , to (due to early repolarization of the right ventricle, see which predisposes these cells to 'all-or-none' repolarizafurther) is also often observed. This syndrome is associated tion. An increase in net outward current or a decrease of with a high mortality rate [137] and is closely related to inward current at the end of phase 1 in epicardial cells may the sudden unexpected death syndrome (SUDS [139] ) explain the ST-segment elevation observed in Brugada described in male Thai patients and responsible for an patients. Augmentation of outward current or decrease of annual mortality rate of 1 / 2500 among young males in inward current at the end of phase 1 would lead to loss of Thailand. A high prevalence of this syndrome is also the epicardial action potential dome and selective abbreviapresent among the Japanese. It displays an autosomal tion of the epicardial action potential giving rise to a dominant inheritance [3] with incomplete penetrance voltage gradient across the myocardium generating the [140, 141] . It affects predominantly men, with the first ST-segment elevation observed in the ECG. In this setting arrhythmic event occurring during the fourth decade of life arrhythmias could arise from phase 2 re-entry secondary to but could also occur in children even during the first the increased epicardial and transmural dispersion of months of life [141] .
repolarization. The prominence of the ECG changes in the Thus far, mutations in SCN5A [3, 142] have been linked right precordial leads could be explained by the fact that to the disorder, however, genetic heterogeneity is sugright ventricular epicardial cells display a larger I (and to gested by the description of a family in whom there was hence more pronounced 'spike-and-dome') than left venabsence of linkage to the SCN5A locus on chromosome 3 tricular epicardial cells [148] . Moreover, it can be hypoth- [143] as well as absence of SCN5A mutation in a cohort of esised that because of the thinness of the right ventricular patients as determined by single-strand conformation polywall, the relative contribution of epicardial action pomorphism analysis methodology (unpublished data).
tentials to the surface ECG is more prominent in right than left precordial leads [135] .
Proposed mechanism for the ECG pattern and
Experiments by Antzelevitch et al. [149] on the canine genesis of arrhythmias right ventricle (on tissue, on myocytes from the respective regions of the wall and on arterially perfused wedges of A mechanism based on transmural differences in action right ventricle) involving modulation of currents (augpotential morphology has been proposed by Antzelevitch mentation of outward current or suppression of inward and co-workers [144, 145] (Fig. 2) . Unlike the endocardial current) at the end of phase 1 of the action potential, have action potential, the epicardial action potential possesses a provided direct evidence that accentuation of epicardial- endocardial action potential heterogeneity underlies the reduce the action potential amplitude, which in turn leads development of ST-segment elevation and the genesis of to a negative shift in the voltage at which phase 1 arrhythmias.
repolarization begins. In experimental systems, flecainide
1
In man, Class IA Na channel blockers such as prohas been shown to selectively shorten the epicardial action cainamide and ajmaline, can induce an elevation of the potential as a result of both this shift and the pronounced ST-segment in the early precordial leads or can increase I in epicardial cells [155] , and cause phase 2 re-excitato pre-existing ST-segment elevations in patients with the tion. Moreover, a decreased I could account for the Na 1
Brugada syndrome [138, 150] see [151] . Class 1C Na conduction disturbances observed in a substantial subset of channel blockers such as flecainide have also been shown patients. In addition, it could be hypothesised that patients to induce ST-segment elevation [152, 153] . In fact, pharmaheterozygous for such 'loss-of-function' mutations have a 1 cological suppression of I is often used to unmask the 50% reduction in Na channels and a similar reduction in Na Brugada ECG in patients previously recognised but with I . However, this is very unlikely and compensatory Na transient normalization [154] . Sodium channel blockade mechanisms are anticipated to play a role since such a 1 has also been proposed to unmask the disorder in relatives drastic reduction in Na current would have disastrous of affected individuals to identify those at risk [154] , consequences on the action potential. although a study by Priori et al. [140] on the other hand,
The other mutations associated with the disorder (Fig. 1 , has demonstrated a lack of correlation between genetic Table 2 ) are an L567Q substitution [141] and a T632M status and the response to the flecainide test in asymptosubstitution [156] both located in the DI-DII linker, an matic gene carriers. Discussion has also been started R1512W substitution [142, 105] located in the DIII-DIV concerning the management of patients in whom Class IC inactivation gate, a T1620M substitution [3] located within antiarrhythmic agents induce J-point elevation [151, 153] .
the S3-S4 linker of DIV and an A1924T substitution [142] As yet no mutations have been identified in these latter in the distal part of the cytoplasmic C-terminal domain. patients.
Functional analysis in Xenopus oocytes of channels There are also profound effects of autonomic stimulation carrying the T1620M substitution [3, 157, 158] demonstraand blockade on ST-segment elevation in Brugada patients ted a faster recovery from inactivation [3, 157, 158] and a [138] . Acetylcholine and b-blockers increase and isopositive shift in the inactivation curve [3, 157, 158] . Moreproterenol mitigates ST-segment elevation.
over, co-expression with the b1-subunit further shifted the mid-point of steady-state inactivation with respect to the 4.2. SCN5A mutations in the Brugada syndrome wild-type channel [157] and accelerated further the recovery from inactivation [157, 158] . The shift of the 1 Since a decrease in Na channel density and conductinactivation curve to more positive potentials (with normal ance was considered to constitute a probable activation kinetics) results in a larger window current and pathophysiological mechanism for the disorder, a candiit has been argued that this could induce hyperexcitability date gene approach directed at SCN5A led to the identificaand an arrhythmogenic substrate in BS patients [157] . tion of SCN5A mutations that co-segregated with the These changes do not readily explain the electrocardisorder in small families [3] and in sporadic cases with diographic phenotype (see also below). In order to gain the disorder [142] . Two types of mutations have been further insight into the mechanism whereby this mutant described (Fig. 1, Table 2 ): mutations possibly leading to a channel causes ST-segment elevation, two separate groups 1 decrease of functional Na channels at the sarcolemma, of investigators [158, 159] have examined this channel in 1 and missense mutations that give rise to Na channels with the mammalian cell line expression system. Baroudi et al. altered biophysical properties. The former category of [158] demonstrated a slower recovery from inactivation mutations include an insertion of two nucleotides (AA) (which is exacerbated by b1-subunit co-expression). On which disrupts the 59 splice site of intron 7 [3] , a deletion the other hand, Dumaine et al. [159] , who investigated the of a single nucleotide (A) at codon 1397 (frameshift characteristics of the mutant channel at a temperature mutation) leading to the creation of an in-frame stop codon (328C) closer to the physiological range described faster and the generation of a truncated protein lacking part of decay and slower reactivation of the current of T1620M DIII, DIV and the C-terminus [3] , and a missense mutation channels. The more rapid decay of I is expected to result Na (R1432G) residing in the P-loop of DIII [105] . Injection of in an outward shift of current flowing in phase 1, leading SCN5A cRNA encoding the frameshift mutation into to abolishment of the action potential dome in epicardial Xenopus oocytes [3] and expression of the R1432G cells. The temperature sensitivity of these changes re-1 channel in tsA-201 cells [105] failed to express Na conciles with the sporadic cases where arrhythmogenic currents. In the case of the splice site mutation, it has not episodes occurred during febrile states. These investigators been demonstrated yet whether this mutation actually also found a positive shift of the steady-state activation results in aberrant splicing or to what extent normal curve that could account for slowed conduction in some splicing is compromised.
patients.
A reduction in Na channel density is expected to Biophysical analysis of R1512W and A1924T mutant channels in Xenopus oocytes [160] demonstrated a negaexogenous coexpression of b1-subunit, findings for retive voltage shift of the steady-state activation and incovery from inactivation for the T1620M channel differ activation curves for R1512W channels and a negative ( Table 2) . voltage shift of the steady-state activation curve for Electrocardiographic features of the LQTS and the BS A1924T. The mechanisms whereby these functional abnormay occur together in the same patient. Recently, we have malities give rise to the Brugada phenotype are yet unclear.
reported on a large 8-generation family characterized by a The substantial negative voltage shift of the steady-state high incidence of nocturnal sudden death and electroactivation of mutant channels may lower the action pocardiographic features of both the LQTS and the BS in the tential threshold thereby increasing excitability. The insame patients [120] . A mutation in SCN5A, 1795insD, crease in window current of these mutants (smaller in the located in the acidic proximal portion of the cytoplasmic case of the R1512W channel since voltage dependence of C-terminal domain, was identified in all electrocarinactivation was also shifted to more negative potentials) diographically affected individuals and underlies the commay increase the depolarizing force early in the course of bined LQTS-BS phenotype. Heterologous expression in the action potential. Once again this does not explain the Xenopus oocytes of 1795insD mutant channels demonelectrocardiographic characteristics of BS. As a highly strated a negative shift of the steady-state inactivation speculative hypothesis one may forward that a sufficient curve and a positive shift of the steady-state activation increase in window current, as a result of the negative shift curve. The resulting reduction of open channel availability of the activation curve [160] of the mutant channels, may upon depolarization is expected to give rise to a reduced 1 lead to depolarizing forces at resting membrane potential. Na current during the action potential upstroke [120] .
Such depolarizations would lead to a larger fraction of Such a reduction in inward Na current is in accordance inactivated channels, consequently decreasing the magwith the Brugada features on the ECG and the slightly 1 nitude of the Na current during the action potential hampered conduction observed in some patients. Whereas upstroke. Similar to mutations more directly leading to in the oocyte expression system no sustained inward reduced inward I , these changes leave I unopposed, current was identified, a small sustained inward current Na to potentially leading to abbreviation of the epicardial action compatible with the LQTS phenotype was found when this potential.
mutant channel was co-expressed with the b1-subunit in When analyzed in tsA-201 cells [105] , voltage-depen-HEK 293 cells [164] . Detailed analysis of current kinetics dence of steady-state activation and inactivation of the in this system revealed that this mutation has opposite R1512W channel were not different from the wild-type effects on the fast and slow components of inactivation. channel. In this expression system however, the mutant Fast inactivation is disrupted, causing the sustained inward channel displayed a slowing of inactivation and a slowing current throughout the action potential plateau and of recovery from inactivation expected to result in deprolonging repolarization at slow heart rates, whereas slow creased channel density available for opening after each inactivation is enhanced, delaying recovery of channel 1 cardiac cycle giving rise to conduction abnormalities. availability between stimuli and reducing the Na current More experiments are needed to gain further insight into at rapid rates. This would lead to enhancement of the the exact mechanism responsible for the electrocar-LQTS phenotype at slow heart rates and enhancement of diographic features of this disorders and the genesis of the Brugada phenotype at higher rates. These findings were arrhythmias. In addition, it is becoming increasingly clear corroborated by ECG-recordings from a patient carrying that caution should be exerted in the interpretation of the 1795insD mutation during rest and with exercise. characteristics of ion channels expressed in heterologous QT-interval was prolonged and ST-segment elevation was expression systems and extrapolation of observations made moderate at rest. With exercise there was an increase of in these systems. For example, channel kinetics are depen-ST-elevation which closely correlated with increase in dent on the expression system used [161] (also for example heart rate, and QT-interval was shortened [164] . compare electrophysiological properties of the R1512W and T1620M channels expressed in oocytes to those 4.3. Patient management obtained in mammalian cells, Table 2 ). The temperature at which channels are analyzed [159, 162] is an important As far as therapy of BS patients is concerned the factor. Moreover, in mammalian cells, conditions that may implantable cardioverter-defibrillator (ICD) has been sugvary could include variation in endogenous expression of gested as the only effective treatment [136] . Because of the b1-subunit and its splice variants [163] as well as a similarly bad prognosis, ICD treatment is also advodifferences in ratio between exogenous / endogenous b1-cated for asymptomatic patients with the typical ECG subunit expression. Nevertheless, at times, different results features [136] . On the other hand, long-term follow-up have also been reported when experimental conditions of isolated patients questions this aggressive approach seem comparable. For example, when comparing data [165, 166] . EP-guided pharmacological treatment with reported by Dumaine et al. [159] and Baroudi et al. [158] , Class IA drugs (quinidine in particular) seems to be safe both in tsA-201 cells, at ambient temperature and without and effective in previously resuscitated Brugada patients [166] . Indeed, experimental data support the concept that quinidine, by virtue of its I blocking effect, might be to effective in BS patients [167] . However, in view of limited patient numbers definite conclusions on the most appropriate treatment modality cannot be derived as yet. This holds in particular for the asymptomatic patients and for the asymptomatic carriers of disease-related mutations with a normal ECG. We have recently demonstrated that cardiac conduction syndrome type 3, the Brugada syndrome and cardiac conduction defects.
Isolated cardiac conduction defects
defects form a third cardiac disorder associated with
The location of the 1795insD SCN5A mutation in this scheme is given as mutations in SCN5A [4] . This also makes SCN5A the first an example. Careful clinical evaluation of patients / families with other SCN5A mutations may unravel overlap in phenotype / s associated with gene identified whose mutation causes an isolated conducthe different mutations and all mutations might find their appropriate tion defect.
place in this scheme.
SCN5A was found to be mutated in two families with different forms of the disease; a progressive form, alsò called Lenegre-Lev disease [168, 169] or progressive cardiac conduction disorder (PCCD), and a non-progressive share clinical features, including conduction defect (PCCD by definition, LQTS and BS), nocturnal sudden cardiac form. The family with the progressive form of the disorder 3 death (BS, LQTS ) that in part seems related to bradyarwas characterized by progressive hampered cardiac con-3 rhythmias, and repolarization disorder (BS, LQTS ). This duction through the His-Purkinje system with right or left 3 suggests that SCN5A-related disorders are more closely bundle branch block and widening of QRS complexes, related than heretofore appreciated. Careful clinical evalualeading to complete atrioventricular block and causing tion may unmask more overlap in phenotype / s associated syncope and sudden death. Linkage was demonstrated to with the different mutations as suggested in the scheme in the SCN5A locus and an SCN5A splice site mutation Fig. 3 and all mutants might find their appropriate place in (IVS2212 T→C) predicted to result in in-frame skipping this scheme. of exon 22 and a product lacking the voltage-sensitive S4 segment of DIV was identified. A locus (HBN1) oǹ chromosome 19q13.3 is also linked to the Lenegre-Lev disease [170, 171] . The gene at this locus however has not 1 1 [62] Makita N, Bennett PB, George Jr. AL. Voltage-gated Na channel b generalized epilepsy associated with a mutation in the Na -channel 1 subunit mRNA expressed in adult human skeletal muscle, heart, b1 subunit gene SCN1B. Nature Genet 1998;19:366-370. 
